<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">BMC Ophthalmol</journal-id>
      <journal-id journal-id-type="iso-abbrev">BMC Ophthalmol</journal-id>
      <journal-title-group>
        <journal-title>BMC Ophthalmology</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1471-2415</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">26189153</article-id>
      <article-id pub-id-type="pmc">4506761</article-id>
      <article-id pub-id-type="publisher-id">75</article-id>
      <article-id pub-id-type="doi">10.1186/s12886-015-0075-2</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Systemic amyloidosis with bilateral conjunctival involvement: a case report</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Correa</surname>
            <given-names>Leandro J.</given-names>
          </name>
          <address>
            <email>leandrocorrea50@hotmail.com</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Maccio</surname>
            <given-names>J. Pablo</given-names>
          </name>
          <address>
            <email>jpablomaccio@hotmail.com</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Esposito</surname>
            <given-names>Evangelina</given-names>
          </name>
          <address>
            <email>gely_e@hotmail.com</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Monti</surname>
            <given-names>Rodolfo</given-names>
          </name>
          <address>
            <email>fitomonti@hotmail.com</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Gonzalez-Castellanos</surname>
            <given-names>M. Eugenia</given-names>
          </name>
          <address>
            <email>eugegonzalezc@hotmail.com</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Paradelo</surname>
            <given-names>Martin</given-names>
          </name>
          <address>
            <email>marti@paradelo.com.ar</email>
          </address>
          <xref ref-type="aff" rid="Aff2"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Serra</surname>
            <given-names>Horacio M.</given-names>
          </name>
          <address>
            <email>hserra@mail.fcq.unc.edu.ar</email>
          </address>
          <xref ref-type="aff" rid="Aff3"/>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Urrets-Zavalia</surname>
            <given-names>Julio A.</given-names>
          </name>
          <address>
            <phone>+54 351 4142150</phone>
            <email>julioaurrets@gmail.com</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <aff id="Aff1"><label/>Department of Ophthalmology, University Clinic Reina Fabiola, Universidad Catolica de Cordoba, Oncativo 1248, Cordoba, 5000 Argentina </aff>
        <aff id="Aff2"><label/>Centro Medico de Patologia y Citopatologia, Cordoba, Argentina </aff>
        <aff id="Aff3"><label/>CIBICI-CONICET, Faculty of Chemical Sciences, Universidad Nacional de Cordoba, Cordoba, Argentina </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>19</day>
        <month>7</month>
        <year>2015</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>19</day>
        <month>7</month>
        <year>2015</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2015</year>
      </pub-date>
      <volume>15</volume>
      <elocation-id>77</elocation-id>
      <history>
        <date date-type="received">
          <day>5</day>
          <month>4</month>
          <year>2015</year>
        </date>
        <date date-type="accepted">
          <day>14</day>
          <month>7</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; Correa et al. 2015</copyright-statement>
        <license license-type="open-access">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0">http://creativecommons.org/licenses/by/4.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
        </license>
      </permissions>
      <abstract id="Abs1">
        <sec>
          <title>Background</title>
          <p>Conjunctival amyloidosis is a very rare condition, generally unilateral, and presents mostly as an isolated condition without systemic compromise. Our purpose is to present a new case of systemic amyloidosis with a bilateral conjunctival involvement.</p>
        </sec>
        <sec>
          <title>Case Presentation</title>
          <p>A 66-years-old caucasian female complaining of conjunctival hemorrhage and chemosis in both eyes for the last five years had been discontinuously treated with topical antibiotics and corticosteroids without any evident improvement. She presented with a pink-yellow infiltration in the inferior conjunctiva of both eyes. Conjunctival biopsy under optical microscopy revealed amyloid deposit, confirmed by Congo red staining. Mucosal biopsy from esophagus and rectus confirmed amyloidosis by Congo red stain. Immunohistochemistry of bone marrow biopsy showed an increased number of plasma cells and an over-expression of light chain kappa subunit. She was treated with corticosteroids and lubrication with an improvement of symptoms. Ocular lesions remained stable after a follow-up of 3&#xA0;years.</p>
        </sec>
        <sec>
          <title>Conclusions</title>
          <p>Conjunctival amyloidosis is a rare entity that may be overlooked, and should be differentiated from chronic conjunctivitis and conjunctival malignancies. Although it presents most frequently as a local process, a systemic involvement should always be ruled out.</p>
        </sec>
      </abstract>
      <kwd-group xml:lang="en">
        <title>Keywords</title>
        <kwd>Ocular amyloidosis</kwd>
        <kwd>Systemic amyloidosis</kwd>
        <kwd>Red eye</kwd>
        <kwd>Conjunctival malignancy</kwd>
      </kwd-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>&#xA9; The Author(s) 2015</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1" sec-type="introduction">
      <title>Background</title>
      <p>Amyloidosis is a rare group of disorders characterized by the deposition of insoluble fibrillar proteins in a &#x3B2;-pleated sheet configuration, known as amyloid, within the extracellular and perivascular space, as the consequence of a wrong folding process of normally soluble proteins, and may affect virtually any organ or tissue of the body [<xref ref-type="bibr" rid="CR1">1</xref>&#x2013;<xref ref-type="bibr" rid="CR5">5</xref>].</p>
      <p>Amyloidosis disorders are classified into three major forms: local, systemic, and hereditary systemic amyloidosis [<xref ref-type="bibr" rid="CR2">2</xref>]. The acquired forms may be primary (immunologic) and secondary (reactive) [<xref ref-type="bibr" rid="CR2">2</xref>]. In primary amyloidosis (AL) deposits contain immunoglobulin light chains, usually lambda and kappa monoclonal types, resulting from the abnormal production by plasmocytes in the bone marrow [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR6">6</xref>]. Secondary amyloidosis (AA) is formed from serum protein A, an acute phase reactant protein that is synthesized in response to longstanding inflammation [<xref ref-type="bibr" rid="CR7">7</xref>]. In hereditary amyloidosis protein deposits are constituted by a mutant form of the transport protein transthyretin [<xref ref-type="bibr" rid="CR8">8</xref>].</p>
      <p>Ocular amyloidosis occurs most frequently as the local deposition of amyloid in the same place where it originates or, rarely, may be part of a systemic disorder [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR9">9</xref>]. Amyloid may accumulate in the eyelid, conjunctiva, cornea, vitreous, or anterior orbit [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR10">10</xref>].</p>
      <p>Conjunctival amyloidosis is one of the most common forms of ocular involvement, mostly occurring as a local deposition of amyloid and rarely in association with systemic involvement [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR10">10</xref>&#x2013;<xref ref-type="bibr" rid="CR15">15</xref>]. Due to the rarity of conjunctival amyloidosis, its diagnosis can often be overlooked or confused with other conditions that may affect the conjunctiva. It is more commonly observed in middle-aged adult patients, presenting as an inflammatory or malignant conjunctival entity [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR11">11</xref>]. Besides, conjunctival malignant lesions can lead to amyloidosis and they should be ruled out [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR12">12</xref>].</p>
      <p>The purpose of our study is to report a new case of systemic amyloidosis with bilateral conjunctival involvement.</p>
    </sec>
    <sec id="Sec2">
      <title>Case presentation</title>
      <p>A 66-year-old Caucasian woman complaining of conjunctival hemorrhage and chemosis in both eyes for the last five years had been discontinuously treated with topical antibiotics and corticosteroids without any evident improvement.</p>
      <p>At the time of her referral, best-corrected visual acuity was 20/25 in both eyes. Biomicroscopy showed significant bilateral and rather symmetric edema of the inferior bulbar and lower fornix conjunctiva with areas of pink-yellow condensation and hemorrhages associated with follicular reaction (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1a</xref>). A conjunctival swap was obtained to rule out infection by common antibiotic resistant bacteria or Chlamydia spp. As direct fluorescent antibodies for Chlamydia spp were positive, she was put under treatment with oral doxycycline 200&#xA0;mg/day and topical azithromycin 3 times/day for 20&#xA0;days, without any improvement. Conjunctival biopsy was undertaken and optical microscopy revealed amorphous eosinophilic material positive for hematoxyline-eosin stain, with mild mono and polymorphonuclear inflammatory infiltrate and hemorrhagic suffusion (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1b</xref> and <xref rid="Fig1" ref-type="fig">1c</xref>). After Congo red staining, the samples showed a red-green birefringence and dichroism under polarized light microscopy consistent with amyloidosis (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1d</xref>). No evidence of malignancy was observed.<fig id="Fig1"><label>Fig. 1</label><caption><p>(<bold>a</bold>)Photograph of the patient showing in both eyes diffuse, yellow-pink diffuse mass extending from the inferior bulbar conjunctiva to the lower fornix with areas of waxy-yellow condensations, prominent intrinsic vessels and subconjunctival hemorrhage. <bold>b</bold> Optical microscopy of conjunctival biopsy shows an amorphous eosinophilic material with mild mono and polymorphonuclear inflammatory infiltrate and hemorrhagic suffusion; (H&amp;E; original magnification x100). <bold>c</bold> A higher magnification shows the amorphous material replacing the normal stroma of the conjunctiva; (H&amp;E; original magnification x400). <bold>d</bold> Polarization microscopy of conjunctival specimen stained with Congo red shows a characteristic red-green birefringence and dichroism of amyloid</p></caption><graphic xlink:href="12886_2015_75_Fig1_HTML" id="MO1"/></fig></p>
      <p>A complete systemic evaluation was carried out. Liver and heart function evaluation was normal. Immunofixation of blood samples revealed polyclonal hypergammaglobulinemy, and no monoclonal bands were observed by immunofixation of urine sample. Mucosal biopsy from esophagus, and rectus confirmed amyloidosis by the Congo red staining (not shown). In order to rule out multiple myeloma or plasma cells dyscrasia, a bone marrow biopsy was obtained showing a positive expression of CD 138+ (Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2a</xref>), a well known marker for identification and quantification of plasma cells in bone marrow and other tissues, as well as an increased population of plasma cells with over-expression of the light chain kappa subunit (Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2b</xref>).<fig id="Fig2"><label>Fig. 2</label><caption><p>Immunohistochemistry of bone marrow biopsy. <bold>a</bold> Staining with specific antibodies for CD 138 show increased number of plasma cells (in brown; x400). <bold>b</bold> Over-expression of immunoglobulin light chain kappa subunit (in orange-brown; x400)</p></caption><graphic xlink:href="12886_2015_75_Fig2_HTML" id="MO2"/></fig></p>
      <p>The patient was treated with topical lubrication and the ocular lesions of both eyes remained stable after a follow-up of 3&#xA0;years. She continues with periodical clinical controls to assess the eventual manifestation and progression of the systemic disease.</p>
    </sec>
    <sec id="Sec3" sec-type="discussion">
      <title>Discussion</title>
      <p>Conjunctival amyloidosis, predominantly affecting middle-aged adults, usually begins at the fornices, spreading to the bulbar and palpebral conjunctiva [<xref ref-type="bibr" rid="CR3">3</xref>]. This progression appears to affect more deeply the palpebral than the bulbar conjunctiva [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR16">16</xref>]. In our patient, a bilateral diffuse pink-yellow infiltration with hemorrhagic areas was found throughout the lower bulbar conjunctiva without affecting the palpebral function and position, in contrast with the findings of Demirci et al [<xref ref-type="bibr" rid="CR4">4</xref>] that observed a unilateral involvement in all of their six cases.</p>
      <p>Associated spontaneous conjunctival hemorrhages, as observed in our patient, are a common finding that may be explained by the fact that amyloid infiltration of vessel walls induces rigidity and disruption of conjunctival vessels [<xref ref-type="bibr" rid="CR3">3</xref>]. A complete systemic evaluation to discard a primary systemic form of the disease is recommended [<xref ref-type="bibr" rid="CR10">10</xref>] as conjunctival amyloidosis might be an early manifestation of systemic amyloidosis [<xref ref-type="bibr" rid="CR3">3</xref>]. In our case, the initial presentation of conjuctival amyloidosis led to the systemic findings that were asymptomatic. Only five cases have been reported as systemic amyloidosis with conjunctival involvement [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR12">12</xref>&#x2013;<xref ref-type="bibr" rid="CR15">15</xref>].</p>
      <p>Even though the condition may be clinically suspected, a tissue biopsy of the involved organ should be taken to confirm the diagnosis. In systemic disease the sampling can be performed directly in the organ or tissue affected, or in a clinically uninvolved site such as subcutaneous fat, minor salivary glands or rectal mucosa [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR3">3</xref>]. Furthermore, testing for monoclonal protein population should be determined by serum and urine protein electrophoresis and immunofixation [<xref ref-type="bibr" rid="CR1">1</xref>]. In our patient, immunofixation of blood samples only revealed polyclonal hypergammaglobulinemy, and rectal and esophageal mucosal biopsies confirmed the diagnosis of systemic amyloidosis. In addition, immunohistochemical studies of bone marrow biopsies showed an increased population of plasma cells with the amyloidogenic overexpression of the subunit kappa.</p>
      <p>There is still no consensus on the management of conjunctival amyloidosis and none of the available treatments are radical. Some authors recommend conservative treatment using lubricants and topical anti-inflammatories [<xref ref-type="bibr" rid="CR3">3</xref>]. Others believe that a more aggressive treatment should be done in order to prevent progression or recurrence [<xref ref-type="bibr" rid="CR17">17</xref>]. Cryotherapy, [<xref ref-type="bibr" rid="CR18">18</xref>] radiotherapy, [<xref ref-type="bibr" rid="CR19">19</xref>] surgical debulking, [<xref ref-type="bibr" rid="CR20">20</xref>] and mucous membrane graft implantation, [<xref ref-type="bibr" rid="CR21">21</xref>] are among the techniques that could be used. A conservative topical treatment was offered to our patient, as lesions remained stable over time and the patient referred no major ocular complaints.</p>
    </sec>
    <sec id="Sec4" sec-type="conclusion">
      <title>Conclusions</title>
      <p>Conjunctival amyloidosis is a rare entity that may be overlooked and should be differentiated from chronic conjunctivitis and conjunctival malignancies. Although commonly a local process, a systemic involvement should always be ruled out.</p>
    </sec>
    <sec id="Sec5">
      <title>Consent</title>
      <p>Written informed consent was obtained from the patient for publication of this Case report and any of the accompanying images. A copy of the written consent is available for review by the Editors of BMC Ophthalmology.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn>
        <p>
          <bold>Competing interests</bold>
        </p>
        <p>The authors declare that they have no competing interests.</p>
      </fn>
      <fn>
        <p>
          <bold>Authors&#x2019; contributions</bold>
        </p>
        <p>LJC participated in the conception and design of the work, drafted the manuscript, participated in the follow-up of patient acquisition, performed in the analysis and interpretation of data, participated in figures selection and edition; manuscript revision and text editing; final manuscript critical revision and correction. JPM performed clinical diagnosis, treatment and follow-up of patient, participated in the conception and design of the work, carried out the analysis and interpretation of data, participated in the final manuscript critical revision, and provided the clinical picture. EE participated in the follow-up of patient, acquisition, analysis and interpretation of data, in writing of the manuscript and text editing, and in the final manuscript critical revision and correction. RM participated in the follow-up of patient, acquisition, analysis and interpretation of data, and in the final manuscript critical revision and correction. MEG-C participated in the follow-up of patient, in the acquisition, analysis and interpretation of data, and in the manuscript revision and correction. MP performed hystopathologic studies, carried out the analysis and interpretation of data and selection of hystopathologic images, and participated in manuscript revision. HMS participated in the writing of the manuscript and text editing, and in the final manuscript critical revision and correction. JAU-Z participated in the conception and design of the work; carried out the analysis and interpretation of data; participated in the writing of the manuscript and text editing, and in the final manuscript critical revision and correction. All authors read and approved the final manuscript, and are accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work were appropriately investigated and resolved.</p>
      </fn>
    </fn-group>
    <ack>
      <title>Acknowledgements</title>
      <p>The authors are grateful to Dr. Ana V. Sanchez and Dr. Ana B. de Diller from the Department of Pathology, Hospital Privado Centro Medico de Cordoba, Argentina, for their invaluable assistance concerning bone marrow biopsy analysis and imaging.</p>
    </ack>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <mixed-citation publication-type="other">Goveric PD. An overview of amiloidosis. UpToDate&#xAE; Wolters Kluwer Health. 2013; <ext-link ext-link-type="uri" xlink:href="http://www.uptodate.com/contents/an-overview-of-amyloidosis">http://www.uptodate.com/contents/an-overview-of-amyloidosis</ext-link></mixed-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Westermark</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Benson</surname>
              <given-names>MD</given-names>
            </name>
            <name>
              <surname>Buxbaum</surname>
              <given-names>JN</given-names>
            </name>
            <name>
              <surname>Cohen</surname>
              <given-names>AS</given-names>
            </name>
            <name>
              <surname>Frangione</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Ikeda</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Amyloid: Toward terminology clarification. Report from the Nomenclature Committee of the International Society of Amyloidosis</article-title>
          <source>Amyloid</source>
          <year>2005</year>
          <volume>12</volume>
          <fpage>1</fpage>
          <lpage>4</lpage>
          <pub-id pub-id-type="doi">10.1080/13506120500032196</pub-id>
          <pub-id pub-id-type="pmid">16076605</pub-id>
        </element-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Leibovitch</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Selva</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Goldberg</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Sullivan</surname>
              <given-names>TJ</given-names>
            </name>
            <name>
              <surname>Saeed</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Davis</surname>
              <given-names>G</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Periocular and orbital amyloidosis: clinical characteristics, management, and outcome</article-title>
          <source>Ophthalmology</source>
          <year>2006</year>
          <volume>113</volume>
          <fpage>1657</fpage>
          <lpage>64</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ophtha.2006.03.052</pub-id>
          <pub-id pub-id-type="pmid">16828514</pub-id>
        </element-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Demirci</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Shields</surname>
              <given-names>CL</given-names>
            </name>
            <name>
              <surname>Eagle</surname>
              <given-names>RC</given-names>
              <suffix>Jr</suffix>
            </name>
            <name>
              <surname>Shields</surname>
              <given-names>JA</given-names>
            </name>
          </person-group>
          <article-title>Conjuctival amyloidosis: report of six cases and review of the literature</article-title>
          <source>Surv Ophthalmol.</source>
          <year>2006</year>
          <volume>51</volume>
          <fpage>419</fpage>
          <lpage>33</lpage>
          <pub-id pub-id-type="doi">10.1016/j.survophthal.2006.04.007</pub-id>
          <pub-id pub-id-type="pmid">16818085</pub-id>
        </element-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Westermark</surname>
              <given-names>GT</given-names>
            </name>
            <name>
              <surname>F&#xE4;ndrich</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Westermark</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>AA amyloidosis: pathogenesis and targeted therapy</article-title>
          <source>Annu Rev Pathol.</source>
          <year>2015</year>
          <volume>10</volume>
          <fpage>321</fpage>
          <lpage>44</lpage>
          <pub-id pub-id-type="doi">10.1146/annurev-pathol-020712-163913</pub-id>
          <pub-id pub-id-type="pmid">25387054</pub-id>
        </element-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Glenner</surname>
              <given-names>GG</given-names>
            </name>
            <name>
              <surname>Terry</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Harada</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Isersky</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Page</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Amyloid fibril proteins: proof of homology with immunoglobulin light chains by sequence analyses</article-title>
          <source>Science.</source>
          <year>1971</year>
          <volume>172</volume>
          <fpage>1150</fpage>
          <lpage>1</lpage>
          <pub-id pub-id-type="doi">10.1126/science.172.3988.1150</pub-id>
          <pub-id pub-id-type="pmid">4102463</pub-id>
        </element-citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lachmann</surname>
              <given-names>HJ</given-names>
            </name>
            <name>
              <surname>Goodman</surname>
              <given-names>HJ</given-names>
            </name>
            <name>
              <surname>Gilbertson</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Gallimore</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Sabin</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>Gillmore</surname>
              <given-names>JD</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Natural history and outcome in systemic AA amyloidosis</article-title>
          <source>N Engl J Med.</source>
          <year>2007</year>
          <volume>356</volume>
          <fpage>2361</fpage>
          <lpage>71</lpage>
          <pub-id pub-id-type="doi">10.1056/NEJMoa070265</pub-id>
          <pub-id pub-id-type="pmid">17554117</pub-id>
        </element-citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rowczenio</surname>
              <given-names>DM</given-names>
            </name>
            <name>
              <surname>Noor</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Gillmore</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Lachmann</surname>
              <given-names>HJ</given-names>
            </name>
            <name>
              <surname>Whelan</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Hawkins</surname>
              <given-names>PN</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Online registry for mutations in hereditary amyloidosis including nomenclature recommendations</article-title>
          <source>Hum Mutat.</source>
          <year>2014</year>
          <volume>35</volume>
          <fpage>E2403</fpage>
          <lpage>12</lpage>
          <pub-id pub-id-type="doi">10.1002/humu.22619</pub-id>
          <pub-id pub-id-type="pmid">25044787</pub-id>
        </element-citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Al-Nuaimi</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Bhatt</surname>
              <given-names>PR</given-names>
            </name>
            <name>
              <surname>Steeples</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Irion</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Bonshek</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Leatherbarrow</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Amyloidosis of the orbit and adnexae</article-title>
          <source>Orbit.</source>
          <year>2012</year>
          <volume>31</volume>
          <fpage>287</fpage>
          <lpage>98</lpage>
          <pub-id pub-id-type="doi">10.3109/01676830.2012.707740</pub-id>
          <pub-id pub-id-type="pmid">22946489</pub-id>
        </element-citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Aryasit</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Preechawai</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Kayasut</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Clinical presentation, treatment, and prognosis of periocular and orbital amyloidosis in a university-based referral center</article-title>
          <source>Clin Ophthalmol.</source>
          <year>2013</year>
          <volume>7</volume>
          <fpage>801</fpage>
          <lpage>5</lpage>
          <pub-id pub-id-type="doi">10.2147/OPTH.S41857</pub-id>
          <pub-id pub-id-type="pmid">23658478</pub-id>
        </element-citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ray</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Tan</surname>
              <given-names>AW</given-names>
            </name>
            <name>
              <surname>Thamboo</surname>
              <given-names>TP</given-names>
            </name>
          </person-group>
          <article-title>Atypical presentation of primary conjuctival amiloidosis</article-title>
          <source>Can J Ophthalmol.</source>
          <year>2012</year>
          <volume>47</volume>
          <fpage>e2</fpage>
          <lpage>4</lpage>
          <pub-id pub-id-type="doi">10.1016/j.jcjo.2011.08.009</pub-id>
          <pub-id pub-id-type="pmid">22333863</pub-id>
        </element-citation>
      </ref>
      <ref id="CR12">
        <label>12.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Abdallah</surname>
              <given-names>AO</given-names>
            </name>
            <name>
              <surname>Westfall</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Brown</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Muzaffar</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Atrash</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Nair</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Unilateral conjunctival AL kappa amyloidosis with trace evidence of systemic amyloidosis</article-title>
          <source>Am J Case Rep.</source>
          <year>2012</year>
          <volume>13</volume>
          <fpage>102</fpage>
          <lpage>5</lpage>
          <pub-id pub-id-type="doi">10.12659/AJCR.883022</pub-id>
          <pub-id pub-id-type="pmid">23569501</pub-id>
        </element-citation>
      </ref>
      <ref id="CR13">
        <label>13.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Purcell</surname>
              <given-names>JJ</given-names>
              <suffix>Jr</suffix>
            </name>
            <name>
              <surname>Birkenkamp</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Tsai</surname>
              <given-names>CC</given-names>
            </name>
            <name>
              <surname>Riner</surname>
              <given-names>RN</given-names>
            </name>
          </person-group>
          <article-title>Conjunctival involvement in primary systemic nonfamilial amyloidosis</article-title>
          <source>Am J Ophthalmol.</source>
          <year>1983</year>
          <volume>95</volume>
          <fpage>845</fpage>
          <lpage>7</lpage>
          <pub-id pub-id-type="doi">10.1016/0002-9394(83)90082-X</pub-id>
          <pub-id pub-id-type="pmid">6859201</pub-id>
        </element-citation>
      </ref>
      <ref id="CR14">
        <label>14.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Iijima</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Primary systemic amyloidosis: a unique case complaining of diffuse eyelid swelling and conjunctival involvement</article-title>
          <source>J Dermatol.</source>
          <year>1992</year>
          <volume>19</volume>
          <fpage>113</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1346-8138.1992.tb03191.x</pub-id>
          <pub-id pub-id-type="pmid">1377722</pub-id>
        </element-citation>
      </ref>
      <ref id="CR15">
        <label>15.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shields</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Eagle</surname>
              <given-names>RC</given-names>
            </name>
            <name>
              <surname>Shields</surname>
              <given-names>CL</given-names>
            </name>
            <name>
              <surname>Green</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Singh</surname>
              <given-names>AD</given-names>
            </name>
          </person-group>
          <article-title>Systemic amyloidosis presenting as a mass of the conjunctival semilunar fold</article-title>
          <source>Am J Ophthalmol.</source>
          <year>2000</year>
          <volume>130</volume>
          <fpage>523</fpage>
          <lpage>5</lpage>
          <pub-id pub-id-type="doi">10.1016/S0002-9394(00)00567-5</pub-id>
          <pub-id pub-id-type="pmid">11024429</pub-id>
        </element-citation>
      </ref>
      <ref id="CR16">
        <label>16.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rodrigues</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Sanghvi</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Lala</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>A rare cause of unilateral upper and lower eyelid swelling: isolated conjuctival amyloidosis</article-title>
          <source>Korean J Ophthalmol.</source>
          <year>2001</year>
          <volume>15</volume>
          <fpage>38</fpage>
          <lpage>40</lpage>
          <pub-id pub-id-type="doi">10.3341/kjo.2001.15.1.38</pub-id>
          <pub-id pub-id-type="pmid">11530820</pub-id>
        </element-citation>
      </ref>
      <ref id="CR17">
        <label>17.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Patrinely</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Koch</surname>
              <given-names>DD</given-names>
            </name>
          </person-group>
          <article-title>Surgical management of advanced ocular adnexal amyloidosis</article-title>
          <source>Arch Ophthalmol.</source>
          <year>1992</year>
          <volume>110</volume>
          <fpage>882</fpage>
          <lpage>5</lpage>
          <pub-id pub-id-type="doi">10.1001/archopht.1992.01080180154045</pub-id>
          <pub-id pub-id-type="pmid">1596239</pub-id>
        </element-citation>
      </ref>
      <ref id="CR18">
        <label>18.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fraunfelder</surname>
              <given-names>FW</given-names>
            </name>
          </person-group>
          <article-title>Liquid nitrogen cryotherapy for conjunctival amyloidosis</article-title>
          <source>Arch Ophthalmol.</source>
          <year>2009</year>
          <volume>127</volume>
          <fpage>645</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="doi">10.1001/archophthalmol.2008.535</pub-id>
          <pub-id pub-id-type="pmid">19433714</pub-id>
        </element-citation>
      </ref>
      <ref id="CR19">
        <label>19.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Khaira</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Mutamba</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Meligonis</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Rose</surname>
              <given-names>GE</given-names>
            </name>
            <name>
              <surname>Plowman</surname>
              <given-names>PN</given-names>
            </name>
            <name>
              <surname>O&#xB4;Donnell</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>The use of radiotherapy for the treatment of localized orbital amyloidosis</article-title>
          <source>Orbit</source>
          <year>2008</year>
          <volume>27</volume>
          <fpage>432</fpage>
          <lpage>7</lpage>
          <pub-id pub-id-type="doi">10.1080/01676830802350216</pub-id>
          <pub-id pub-id-type="pmid">19085298</pub-id>
        </element-citation>
      </ref>
      <ref id="CR20">
        <label>20.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Murdoch</surname>
              <given-names>IE</given-names>
            </name>
            <name>
              <surname>Sullivan</surname>
              <given-names>TJ</given-names>
            </name>
            <name>
              <surname>Moseley</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Hawkins</surname>
              <given-names>PN</given-names>
            </name>
            <name>
              <surname>Pepys</surname>
              <given-names>MB</given-names>
            </name>
            <name>
              <surname>Tan</surname>
              <given-names>SY</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Primary localized amyloidosis of the orbit</article-title>
          <source>Br J Ophthalmol.</source>
          <year>1996</year>
          <volume>80</volume>
          <fpage>1083</fpage>
          <lpage>6</lpage>
          <pub-id pub-id-type="doi">10.1136/bjo.80.12.1083</pub-id>
          <pub-id pub-id-type="pmid">9059275</pub-id>
        </element-citation>
      </ref>
      <ref id="CR21">
        <label>21.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Seider</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Beiran</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Kaltreider</surname>
              <given-names>SA</given-names>
            </name>
          </person-group>
          <article-title>Advanced localized primary conjunctival amyloidosis: surgical rehabilitation using mucous membrane graft implantation</article-title>
          <source>Isr Med Assoc J.</source>
          <year>2006</year>
          <volume>8</volume>
          <fpage>439</fpage>
          <lpage>40</lpage>
          <pub-id pub-id-type="pmid">16833179</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
